Saturday, June 4th
9:00 am – 1:15 pm (Breakfast Included)
Ridgeline Hotel, Estes Park, CO

Point-of-care testing empowers clinicians to use effective, fast technology to aid their decision making at the “point-of-care” to improve patient health. Pharmacy-based point-of-care testing utilizes CLIA-waived (Clinical Laboratory Improvement Amendments -waived) tests that offer near immediate results in non-laboratory settings.  Pharmacists and pharmacies are increasingly offering this public health service to promote prevention, early detection, and disease management.

Activity Description

The NASPA Pharmacy-based Point-of-Care Test & Treat National Certificate Program provides an opportunity to gain the skills and information necessary to develop a testing program for influenza, Group A Streptococcus, HIV, Hepatitis C and coronaviruses. The target audience for the certificate program is pharmacists, pharmacy technicians, student pharmacists, schools and colleges of pharmacy, and pharmacy association staff. While the program is primarily designed for pharmacists, non-pharmacists interested in point-of-care testing are also welcome to complete the program.

The 20-hour ACPE-accredited certificate program includes comprehensive material regarding key disease states, physical assessment, point-of-care tests, collaborative practice models, and business models through:

• 16 hours of home study
• 4 hours of live training

Participants take an online assessment after each of the 12 modules of home study, in addition to a cumulative assessment (must pass 70% within three attempts), and then their proficiency to conduct physical assessments and offer point-of-care testing services is assessed in the live/virtual training. Upon successful completion of both portions of the program and all program evaluations, participants are awarded a certificate of completion and pharmacists can receive 20 hours of Continuing Pharmacy Education (CPE) credit.

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

• Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
• Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
• Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
• Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
• Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, Appropriate treatment, Point-of-Care testing.
• Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose.
• Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance.
• Apply all information to patient-specific cases based on common pharmacy-based patient interaction.

At the completion of this activity, the pharmacy technician will be able to:

• Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
• Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
• Describe and perform under the supervision of a pharmacist the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
• Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
• Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, and Point-of-Care testing.
• Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose.
• Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests.

CPE credit: home study plus live training

This course offers 20 hours of ACPE CE (16 home study, 4 live training)

Students take an online assessment after each of the 12 modules of home study, in addition to a cumulative assessment (must pass 70% within three attempts), and then their proficiency to conduct physical assessments and offer point-of-care testing services is assessed in the live training. Upon successful completion of both portions of the program and all program evaluations, participants are awarded a certificate of completion and can receive 20 hours of Continuing Pharmacy Education (CPE) credit.

Please CLICK HERE for a detailed outline of all 12 modules.

Target Audience

This course provides pharmacists, pharmacy technicians, and student pharmacists with the skills necessary to develop a testing program for influenza, Group A streptococcus, HIV, hepatitis C, and Coronavirus.

Member: Pharmacist	$349.00
Non-Member: Pharmacist	$499.00
Resident	$259.00
Student/Tech	$199.00

Continuing Education Information:

Program Information

Pharmacy-based Point-of-Care Test & Treat National Certificate Program

ACPE Universal Activity #0112-0000-22-200-B04-P/T
Activity Type: Practice-based
Target Audience: Pharmacists and pharmacy technicians in all practice settings
Release Date: January 3, 2022
Expiration Date: January 3, 2025
Contact Hours: 20.0

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

• Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
• Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
• Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
• Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
• Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, Appropriate treatment, Point-of-Care testing.
• Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose.
• Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance.
• Apply all information to patient-specific cases based on common pharmacy-based patient interaction.

At the completion of this activity, the pharmacy technician will be able to:

• Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
• Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
• Describe and perform under the supervision of a pharmacist the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
• Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
• Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, and Point-of-Care testing.
• Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose.
• Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests.

Target Audience

This course provides pharmacists, pharmacy technicians, and student pharmacists with the skills necessary to develop a testing program for influenza, Group A streptococcus, HIV, hepatitis C, and Coronavirus.

Claiming Credit

Successful completion of the live/virtual seminar component involves passing the final exam with a grade of 70 percent or higher and demonstrating proficiency in diagnostic testing techniques. Successful completion of the self-study component involves passing the self-study assessment questions with a grade of 70 percent or higher. Credit is only awarded for completion of the entire 20 contact hour program. Credit must be claimed within 30 days of completing the program (no exceptions). Attendance and participation are required before obtaining CPE credit. Partial credit will not be awarded.

CPE Monitor, is a national, collaborative effort by the Accreditation Council for Pharmacy Education (ACPE) and the National Association of Boards of Pharmacy (NABP) to provide an electronic system for pharmacists and pharmacy technicians to track their completed PCE credits. This system allows pharmacists and pharmacy technicians to log into a comprehensive electronic profile to access information about their completed CPE. All ACPE-accredited providers will be required to use this system. CPE Statements of Credit will no longer be mailed.

All continuing education credits provided by the Michigan Pharmacists Association (MPA) will be uploaded to the CPE Monitor by Lecture Panda.  Lecture Panda is a platform that MPA utilizes to submit your CPE credits. You can access all certificate program materials – learning modules, PowerPoint slides, additional learning materials, assessments, and evaluations in this platform. As soon as you complete your evaluation and other instructions, it is validated and automatically sent to CPE Monitor for accreditation so there is no wait time to receive credit. After CPE credits are processed by ACPE and NABP, pharmacists and pharmacy technicians are able to log into their NABP e-Profile and view all of their completed ACPE-accredited CPE credit.

In order to process CPE credits, please provide Lecture Panda with your correct NABP e-Profile ID number and your birth month and day (MMDD format).  The NABP e-Profile ID number is currently a 6-digit number, and it is not your license number or NPI number.  If you need to verify the number or have not yet registered for one, visit www.MyCPEMonitor.net as soon as possible.

Michigan Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Cancellation policy

No refunds are available for this program. Should CPS cancel this program, you are entitled to a full refund.

If you need to cancel your registration, please notify CPS in writing immediately. No refunds will be given due to registration cancellation, but timely notification of a cancellation may allow another person to participate in your place.

If you have questions about this program please contact CPS at admin@copharm.org.